Header list of 1e9j.pdb file
Complete list - l 29 2 Bytes
HEADER GLYCOPROTEIN 18-OCT-00 1E9J
TITLE SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN
TITLE 2 [INCLUDING A SINGLE GLCNAC RESIDUE AT ASN52 AND ASN78]
CAVEAT 1E9J NAG A 102 HAS WRONG CHIRALITY AT ATOM C1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CHORIONIC GONADOTROPIN;
COMPND 3 CHAIN: A;
COMPND 4 OTHER_DETAILS: GLYCOSYLATED AT ASN52 AND ASN78
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 OTHER_DETAILS: ISOLATED FROM URINE OF PREGNANT WOMEN
KEYWDS GLYCOPROTEIN, CHORIONIC GONADOTROPIN, HCG, XPLOR
EXPDTA SOLUTION NMR
NUMMDL 26
AUTHOR P.J.A.ERBEL,Y.KARIMI-NEJAD,J.A.VAN KUIK,R.BOELENS,J.P.KAMERLING,
AUTHOR 2 J.F.G.VLIEGENTHART
REVDAT 8 29-JUL-20 1E9J 1 COMPND REMARK HETNAM LINK
REVDAT 8 2 1 SITE
REVDAT 7 17-JAN-18 1E9J 1 SOURCE AUTHOR JRNL
REVDAT 6 12-JUL-17 1E9J 1
REVDAT 5 19-OCT-11 1E9J 1 REMARK HETSYN VERSN
REVDAT 4 24-FEB-09 1E9J 1 VERSN
REVDAT 3 24-JUL-03 1E9J 1 JRNL
REVDAT 2 24-JUN-03 1E9J 1 HET HETSYN SSBOND LINK
REVDAT 2 2 1 ATOM HETATM CONECT
REVDAT 1 25-JUL-02 1E9J 0
JRNL AUTH P.J.ERBEL,Y.KARIMI-NEJAD,J.A.VAN KUIK,R.BOELENS,
JRNL AUTH 2 J.P.KAMERLING,J.F.VLIEGENTHART
JRNL TITL EFFECTS OF THE N-LINKED GLYCANS ON THE 3D STRUCTURE OF THE
JRNL TITL 2 FREE ALPHA-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN.
JRNL REF BIOCHEMISTRY V. 39 6012 2000
JRNL REFN ISSN 0006-2960
JRNL PMID 10821673
JRNL DOI 10.1021/BI992786N
REMARK 2
REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1E9J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-OCT-00.
REMARK 100 THE DEPOSITION ID IS D_1290005454.
REMARK 210
REMARK 210 EXPERIMENTAL DETAILS
REMARK 210 EXPERIMENT TYPE : NMR
REMARK 210 TEMPERATURE (KELVIN) : 328
REMARK 210 PH : 5.1
REMARK 210 IONIC STRENGTH : 100
REMARK 210 PRESSURE : NULL
REMARK 210 SAMPLE CONTENTS : NULL
REMARK 210
REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL
REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ
REMARK 210 SPECTROMETER MODEL : DRX; AMX; UNITY
REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN
REMARK 210
REMARK 210 STRUCTURE DETERMINATION.
REMARK 210 SOFTWARE USED : X-PLOR
REMARK 210 METHOD USED : DG/SA
REMARK 210
REMARK 210 CONFORMERS, NUMBER CALCULATED : 100
REMARK 210 CONFORMERS, NUMBER SUBMITTED : 26
REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL
REMARK 210
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1
REMARK 210
REMARK 210 REMARK: STRUCTURAL STATISTICS FOR THE FAMILY OF 27 AHCG CONFORMERS
REMARK 210 EXCLUDE THE FLEXIBLE LOOP AND ENDS, SEGMENTS 1-10, 29-58 AND 85-
REMARK 210 92 (SEE REFERENCE)
REMARK 215
REMARK 215 NMR STUDY
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION
REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON
REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O THR A 11 H MET A 29 1.57
REMARK 500 O GLN A 20 H GLY A 22 1.60
REMARK 500 O VAL A 76 N ASN A 78 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 1 ASP A 3 -144.81 -161.34
REMARK 500 1 GLN A 5 22.56 48.42
REMARK 500 1 PRO A 8 -168.08 -79.92
REMARK 500 1 CYS A 10 129.95 -28.83
REMARK 500 1 THR A 11 -169.69 175.86
REMARK 500 1 GLN A 13 62.71 -112.36
REMARK 500 1 GLU A 14 125.72 -0.20
REMARK 500 1 PHE A 17 -53.38 -126.99
REMARK 500 1 PRO A 21 67.97 -53.37
REMARK 500 1 PRO A 24 65.40 -107.55
REMARK 500 1 ILE A 25 -175.69 -39.11
REMARK 500 1 LEU A 26 -158.72 -150.88
REMARK 500 1 GLN A 27 86.34 161.75
REMARK 500 1 CYS A 28 111.49 -31.98
REMARK 500 1 CYS A 32 30.75 -91.92
REMARK 500 1 PHE A 33 -170.95 61.88
REMARK 500 1 LEU A 41 -141.43 -80.85
REMARK 500 1 SER A 43 86.86 58.39
REMARK 500 1 LYS A 44 -81.34 -48.74
REMARK 500 1 LYS A 45 -155.88 -61.82
REMARK 500 1 THR A 46 167.48 -34.73
REMARK 500 1 MET A 47 -40.40 -27.20
REMARK 500 1 GLN A 50 -176.07 62.12
REMARK 500 1 SER A 55 105.05 60.19
REMARK 500 1 GLU A 56 -34.68 -160.83
REMARK 500 1 SER A 57 60.21 -69.94
REMARK 500 1 CYS A 60 52.54 -109.76
REMARK 500 1 VAL A 61 87.23 -46.90
REMARK 500 1 ALA A 62 111.75 -0.93
REMARK 500 1 ARG A 67 129.48 -7.06
REMARK 500 1 THR A 69 118.34 -22.20
REMARK 500 1 VAL A 70 -164.07 -112.53
REMARK 500 1 MET A 71 147.46 -26.77
REMARK 500 1 PHE A 74 174.72 -52.60
REMARK 500 1 GLU A 77 40.95 24.88
REMARK 500 1 ASN A 78 67.95 -0.41
REMARK 500 1 CYS A 84 170.66 -48.88
REMARK 500 1 SER A 85 -165.62 58.71
REMARK 500 1 THR A 86 97.86 42.58
REMARK 500 1 TYR A 89 89.14 169.16
REMARK 500 1 LYS A 91 79.57 78.54
REMARK 500 2 PRO A 2 46.99 -78.28
REMARK 500 2 ASP A 6 123.73 -34.47
REMARK 500 2 CYS A 7 76.29 -172.09
REMARK 500 2 PRO A 8 -155.96 -51.94
REMARK 500 2 THR A 11 -165.71 -165.10
REMARK 500 2 GLN A 13 51.77 -106.71
REMARK 500 2 GLU A 14 122.37 -1.66
REMARK 500 2 PHE A 17 -62.29 -103.13
REMARK 500 2 SER A 19 108.80 -51.36
REMARK 500
REMARK 500 THIS ENTRY HAS 1122 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1DZ7 RELATED DB: PDB
REMARK 900 SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN
REMARK 900 [MODELED WITHOUT CARBOHYDRATE RESIDUES]
REMARK 900 RELATED ID: 1QFW RELATED DB: PDB
REMARK 900 TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA
REMARK 900 SUBUNIT AND FV ANTI BETA SUBUNIT
REMARK 900 RELATED ID: 1XUL RELATED DB: PDB
REMARK 900 THEORETICAL MODEL OF THE LIGAND-BINDING REGION OF LUTROPIN RECEPTOR
REMARK 900 COMPLEXED WITH HUMAN CHORIONIC GONADOTROPIN
REMARK 900 RELATED ID: 1HRP RELATED DB: PDB
REMARK 900 HUMAN CHORIONIC GONADOTROPIN (HCG)
REMARK 900 RELATED ID: 1HCN RELATED DB: PDB
REMARK 900 HUMAN CHORIONIC GONADOTROPIN (HCG)
DBREF 1E9J A 1 92 UNP P01215 GLHA_HUMAN 25 116
SEQRES 1 A 92 ALA PRO ASP VAL GLN ASP CYS PRO GLU CYS THR LEU GLN
SEQRES 2 A 92 GLU ASN PRO PHE PHE SER GLN PRO GLY ALA PRO ILE LEU
SEQRES 3 A 92 GLN CYS MET GLY CYS CYS PHE SER ARG ALA TYR PRO THR
SEQRES 4 A 92 PRO LEU ARG SER LYS LYS THR MET LEU VAL GLN LYS ASN
SEQRES 5 A 92 VAL THR SER GLU SER THR CYS CYS VAL ALA LYS SER TYR
SEQRES 6 A 92 ASN ARG VAL THR VAL MET GLY GLY PHE LYS VAL GLU ASN
SEQRES 7 A 92 HIS THR ALA CYS HIS CYS SER THR CYS TYR TYR HIS LYS
SEQRES 8 A 92 SER
MODRES 1E9J ASN A 52 ASN GLYCOSYLATION SITE
MODRES 1E9J ASN A 78 ASN GLYCOSYLATION SITE
HET NAG A 101 23
HET NAG A 102 23
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
FORMUL 2 NAG 2(C8 H15 N O6)
HELIX 1 AA1 VAL A 70 PHE A 74 5 5
SSBOND 1 CYS A 7 CYS A 31 1555 1555 2.03
SSBOND 2 CYS A 10 CYS A 60 1555 1555 2.03
SSBOND 3 CYS A 28 CYS A 82 1555 1555 2.03
SSBOND 4 CYS A 32 CYS A 84 1555 1555 2.03
SSBOND 5 CYS A 59 CYS A 87 1555 1555 2.03
LINK ND2 ASN A 52 C1 NAG A 101 1555 1555 1.45
LINK ND2 ASN A 78 C1 NAG A 102 1555 1555 1.44
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000
MODEL 1
Complete list - l 29 2 Bytes